Cargando…

Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma

Pancreatic ductal adenocarcinoma (PDAC) is a cancer type with one of the highest mortalities. The metalloprotease-disintegrin ADAM8 is highly expressed in pancreatic cancer cells and is correlated with an unfavorable patient prognosis. However, no information is available on ADAM8 expression in cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaworek, Christian, Verel-Yilmaz, Yesim, Driesch, Sarah, Ostgathe, Sarah, Cook, Lena, Wagner, Steffen, Bartsch, Detlef K., Slater, Emily P., Bartsch, Jörg W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916368/ https://www.ncbi.nlm.nih.gov/pubmed/33578644 http://dx.doi.org/10.3390/jpm11020113

Ejemplares similares

Extracellular Vesicle-Based Detection of Pancreatic Cancer
por: Verel-Yilmaz, Yesim, et al.
Publicado: (2021)

Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors
por: Cuffaro, Doretta, et al.
Publicado: (2021)

ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9
por: Cook, Lena, et al.
Publicado: (2022)

Expression of the Metalloproteinase ADAM8 Is Upregulated in Liver Inflammation Models and Enhances Cytokine Release In Vitro
por: Awan, Tanzeela, et al.
Publicado: (2021)

Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC
por: Strell, Carina, et al.
Publicado: (2017)

PRMT1 promotes the tumor suppressor function of p14(ARF) and is indicative for pancreatic cancer prognosis
por: Repenning, Antje, et al.
Publicado: (2021)

The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
por: Geyer, Marlene, et al.
Publicado: (2023)

Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
por: Götze, Julian, et al.
Publicado: (2022)

ADAM8 signaling drives neutrophil migration and ARDS severity
por: Conrad, Catharina, et al.
Publicado: (2022)

Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells
por: Awan, Tanzeela, et al.
Publicado: (2020)

In Silico analyses of host immunity and stroma provide prognostic factors in early stage pancreatic ductal adenocarcinoma (PDAC)
por: Williams, Madison H., et al.
Publicado: (2020)

ADAM8 as a drug target in Pancreatic Cancer
por: Schlomann, Uwe, et al.
Publicado: (2015)

IL-17A-producing CD8(+) T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts
por: Picard, Felix Simon Ruben, et al.
Publicado: (2023)

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis
por: Romagnoli, Mathilde, et al.
Publicado: (2014)

A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models
por: Chen, Jun, et al.
Publicado: (2016)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
por: Oria, Victor O., et al.
Publicado: (2019)

Transverse Space Charge Effect During Bunch Compression in PDAC1 and PDAC2 Compressor Ring
por: Franchetti, Giuliano
Publicado: (2000)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

Selective estrogen receptor modulators decrease invasiveness in pituitary adenoma cell lines AtT‐20 and TtT/GF by affecting expression of MMP‐14 and ADAM12
por: Zhang, Zhuo, et al.
Publicado: (2020)

Role of microbiota and microbiota‐derived short‐chain fatty acids in PDAC
por: Temel, Hülya Yılmaz, et al.
Publicado: (2022)

German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program
por: Franke, Frederike S., et al.
Publicado: (2018)

Autophagy is required for PDAC glutamine metabolism
por: Seo, Ju-Won, et al.
Publicado: (2016)

SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells
por: Li, Siqin, et al.
Publicado: (2016)

Fungal ablation and transplantation of specific fungal species into PDAC tumor-bearing mice
por: Alam, Aftab, et al.
Publicado: (2022)

The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma
por: Liu, Xiaojin, et al.
Publicado: (2022)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

The Microbiome in PDAC—Vantage Point for Future Therapies?
por: Pfisterer, Nina, et al.
Publicado: (2022)

The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness
por: Schäfer, Agnes, et al.
Publicado: (2022)

A Disintegrin and Metalloproteinase Protein 8 (ADAM 8) in Autism Spectrum Disorder: Links to Neuroinflammation
por: Al-Ayadhi, Laila, et al.
Publicado: (2023)

Isolation and adoptive transfer of innate lymphoid cells 2 to a recipient mouse model of PDAC
por: Alam, Aftab, et al.
Publicado: (2022)

The sheddase ADAM10 is a potent modulator of prion disease
por: Altmeppen, Hermann C, et al.
Publicado: (2015)

Adams-Iwasawa N=8 Black Holes
por: Cacciatori, Sergio Luigi, et al.
Publicado: (2012)

Combatting PDAC with two tumor-targeting small RNAs
por: Kasinski, Andrea L.
Publicado: (2019)

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
por: Digiacomo, Graziana, et al.
Publicado: (2021)

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
por: Malinova, Antonia, et al.
Publicado: (2021)

Loss of FGFR4 promotes the malignant phenotype of PDAC
por: D’Agosto, Sabrina, et al.
Publicado: (2022)

Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Palladin Mutation Causes Familial Pancreatic Cancer: Absence in European Families
por: Slater, Emily, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_k0cgc67octsep0ptj4a3omorg5